Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Stacy

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Movement Disorders Clinical Practice|October 25, 2016
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient RegistryEric S Molho, Mark Stacy, Patrick Gillard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2019
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important differenceMark Stacy, Martha Sajatovic, John M Kane, et al.
Parkinsonism & Related Disorders|February 20, 2018
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?Kelvin L Chou, Mark Stacy, Tanya Simuni, et al.
Journal of Neurology|April 23, 2014
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)P David Charles, Charles H Adler, Mark Stacy, et al.
The Lancet. Neurology|March 15, 2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trialRobert A Hauser, Ann Hsu, Sherron Kell, et al.
Brain Research|November 7, 2002
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptorsJ N Joyce, H L Ryoo, T B Beach, et al.
BMC Neurology|November 8, 2011
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)Joseph Jankovic, Charles H Adler, P David Charles, et al.
Archives of Neurology|May 12, 2010
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patientsDaniel Weintraub, Juergen Koester, Marc N Potenza, et al.
Annals of Neurology|March 19, 2011
Impulse control disorders in Parkinson disease: a multicenter case--control studyValerie Voon, Mandy Sohr, Anthony E Lang, et al.
Annals of Neurology|December 15, 2010
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional studyDaniel Weintraub, Mandy Sohr, Marc N Potenza, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Movement Disorders Clinical Practice|October 25, 2016
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient RegistryEric S Molho, Mark Stacy, Patrick Gillard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 25, 2019
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important differenceMark Stacy, Martha Sajatovic, John M Kane, et al.
Parkinsonism & Related Disorders|February 20, 2018
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?Kelvin L Chou, Mark Stacy, Tanya Simuni, et al.
Journal of Neurology|April 23, 2014
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)P David Charles, Charles H Adler, Mark Stacy, et al.
The Lancet. Neurology|March 15, 2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trialRobert A Hauser, Ann Hsu, Sherron Kell, et al.
Brain Research|November 7, 2002
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptorsJ N Joyce, H L Ryoo, T B Beach, et al.
BMC Neurology|November 8, 2011
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)Joseph Jankovic, Charles H Adler, P David Charles, et al.
Archives of Neurology|May 12, 2010
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patientsDaniel Weintraub, Juergen Koester, Marc N Potenza, et al.
Annals of Neurology|March 19, 2011
Impulse control disorders in Parkinson disease: a multicenter case--control studyValerie Voon, Mandy Sohr, Anthony E Lang, et al.
Annals of Neurology|December 15, 2010
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional studyDaniel Weintraub, Mandy Sohr, Marc N Potenza, et al.
Pageof 7